Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: Effect of tacrine treatment

Dementia and Geriatric Cognitive Disorders

Volumn 8, Issue 2, 1997, Pages 78-84

  Nordberg, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; imaging; muscarinic receptors; neuroreceptor; nicotinic receptors; PET; tacrine

Indexed keywords

BENZATROPINE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; TACRINE;

ADULT; AGED; ALZHEIMER DISEASE; BRAIN CORTEX; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0031002186     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106611     Document Type: Conference Paper

References (3)

1. Rappoport S: Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review. Cerebrovasc Brain Metab Rev 1991;3:297-335.
2. Nordberg A: Clinical studies in Alzheimer patients with positron emission tomography. Behav Brain Res 1993;57:215-224.
3. Waldemar G: Functional brain imaging with SPECT in normal aging and dementia - Methodological, pathophysiological, and diagnostic aspects. Cerebrovasc Brain Metab Rev 1995;7:89-130.